Current Trends in Clinical Development of Gene and Cellular Therapeutic Products for Cancer in Japan
Abstract
Purpose In Japan, gene therapy and cellular therapy are categorized as regenerative medicine products based on the Pharmaceuticals and Medical Devices Law that was implemented in 2014. In this new law, regenerative medicine products were newly defined, and a conditional and term-limited approval system for regenerative medicine products was instituted. In addition, the Ministry of Health, Labour and Welfare instituted the SAKIGAKE (meaning...
Paper Details
Title
Current Trends in Clinical Development of Gene and Cellular Therapeutic Products for Cancer in Japan
Published Date
Jan 1, 2019
Journal
Volume
41
Issue
1
Pages
174 - 184.e3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History